Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Thrombosis Research|November 12, 2019
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulantsGeorges Jourdi, Maxime Delrue, Alain Stepanian, et al.Thrombosis and Haemostasis|February 9, 2026
Characterization of monocyte subsets in a prospective cohort of patients with acute stroke suspicion: results of BOOST studyEvelyne Heng, Marie Neuwirth, Floriane Mas, et al.Frontiers in Immunology|December 26, 2022
Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life studyPierre-Edouard Debureaux, Stéphanie Harel, Nathalie Parquet, et al.Research and Practice in Thrombosis and Haemostasis|August 18, 2025
Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapyGeoffrey Foulon-Pinto, Georges Jourdi, Maxime Delrue, et al.Thrombosis and Haemostasis|December 17, 2013
A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodaroneCaroline Moreau, Eric Pautas, Charlotte Duverlie, et al.Journal of Thrombosis and Haemostasis : JTH|June 20, 2019
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variabilityVirginie Siguret, Johan Abdoul, Xavier Delavenne, et al.Thrombosis and Haemostasis|November 17, 2022
Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly PatientsGeoffrey Foulon-Pinto, Carmelo Lafuente-Lafuente, Georges Jourdi, et al.Anaesthesia, Critical Care & Pain Medicine|January 4, 2023
Anaesthetic and peri-operative management for thrombectomy procedures in stroke patientsHervé Quintard, Vincent Degos, Mikael Mazighi, et al.Journal of Thrombosis and Haemostasis : JTH|May 10, 2024
Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitorsMark Schreuder, Georges Jourdi, Dejvid Veizaj, et al.Journal of Thrombosis and Haemostasis : JTH|May 18, 2024
The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopeniaCaroline Vayne, Jérôme Rollin, Rumi Clare, et al.Pageof 9